Skip to content

AMCG

R&DQuantum-Powered Clinical Intelligence

MCG-S

Magnetocardiography system for diagnosis
MFDS approved · US FDA 510(k) cleared
The world's first 96-channel magnetocardiography device.It measures the extremely faint magnetic field produced by the electrophysiological activity of the heart from outside the body,then quantifies myocardial ischemia and electrophysiological abnormalities with AI algorithms.

MCG-S

  • 01

    96-channel high-density measurement

    Covers the whole heart at once and localizes the lesion in three dimensions.

  • 02

    2nd-generation DROS sensor

    Our own sensor delivers 10× the signal sensitivity of a 1st-generation DC-SQUID.

  • 03

    Helium reliquefaction

    Expensive helium is reliquefied and reused, cutting operating cost substantially.

  • 04

    No radiation, no contrast

    A non-invasive, non-pharmacological test that carries no burden for repeat or long-term follow-up.

Channels96
Sensor2nd-generation DROS SQUID
Test timeAbout 5 minutes
Sensitivity / specificityOver 90%
CoolingHelium reliquefaction loop
ApprovalsMFDS, US FDA 510(k)